崔博士具有扎实的生物学及生物医学的研究背景。他持有哈佛大学的生物化学及分子药理学博士学位，还在就读期间获得了Karnovsky奖学金和Fu 奖学金。作为哈佛大学的毕业生，他构思、建立并维系了一项由哈佛医学院、加州大学圣地亚哥分校和中国科学院共同参与的重要长期合作项目。他的关于病毒微小RNA 的突破性发现作为编辑特选的极具影响力的文章，发表在《病毒学学报》（Journal of Virology）的“焦点”（Spotlight）专栏。崔博士拥有北京大学生物技术理学学士学位，在北京大学就读期间，他获得了叔苹奖学金并当选毕业生致辞代表，他的关于抗乳腺癌的免疫疗法研究和论文还获得了优秀本科生毕业论文奖。除了为学术领域的客户提供专利申请和其他知识产权方面的法律咨询外，崔博士还担任《国际科学期刊》（Scientific Journals International）的编委会委员，继续为科研界做出贡献。他是该期刊的生物学部唯一一位并非在学术界、产业界或政府任职的编委。
在加入美富前，崔博士曾先后在美国一家顶级知识产权法专业律师事务所和一家跨国律师事务所的久负盛名的知识产权部担任美国专利代理人。崔博士以极优等毕业生的荣誉（magna cum laude）获得纽约大学法学院法学博士学位。在纽约大学就读期间，他曾经担任《纽约大学法律与商业学报》（NYU Journal of Law & Business）的资深编辑及编委会委员。他是美国杰出法律学会白帽协会（The Order of the Coif）的荣誉会员，也是纽约大学法学院唯一的知识产权法毕业生荣誉奖得主。崔博士一直保持着对于专利法（尤其是客体专利适格性）和信息隐私权法的学术研究兴趣，他在这两个领域均有著述。
Dr. Can Cui is a member of the firm’s Technology Transactions Group and one of the leading practitioners in biotech and life sciences recognized by Berkeley Center for Law & Technology. His practice focuses on China-related life sciences transactions, including cross-border technology licensing and acquisitions, collaboration and strategic partnerships, joint ventures, and other forms of investments.
Can has extensive experience representing both technology licensors and licensees in life sciences licensing transactions, both domestic and across the Pacific. In private equity and venture capital transactions, he has advised institutional and individual investors, established life sciences companies and startups on intellectual property (IP) and technology due diligence matters, and negotiated and drafted related investment documentation. Can also advises clients on the IP aspects of mergers and acquisitions.
Can is also a member of the firm’s IP Group. For more than thirteen years, Can has prepared and prosecuted numerous patent applications in the United States in the areas of biotechnology, chemistry, medical devices, pharmaceuticals, and Internet technologies. Prior to his arrival in the Bay Area, Can was resident in the firm’s Hong Kong office for four years, where he managed patent infringement and invalidation proceedings in China on behalf of the firm’s U.S. technology clients and gained extensive experience in IP dispute resolution in China. He is a frequent guest lecturer at top universities in the United States and in China on U.S. patent law, patent licensing, and IP protection in the biotech industry, and he established and taught Chinese IP law at The Chinese University of Hong Kong for three years as an adjunct faculty member.
Can has a strong research background in biological and biomedical sciences. He was the recipient of the Karnovsky Fellowship and the Fu Fellowship at Harvard University, where he obtained his Ph.D. in biological chemistry & molecular pharmacology. As a graduate student at Harvard, he conceived, established, and maintained a major long-term collaborative project among Harvard Medical School, the University of California, San Diego, and the Chinese Academy of Sciences. His groundbreaking identification of a viral microRNA was featured in the “Spotlight” section of Journal of Virology as an article of significant interest selected by the editors. Can was a Shuping Scholar and valedictorian at Peking University, where he received his B.Sc. in biotechnology, with high distinction honor for his research and senior thesis on anti-breast cancer immunotherapy.
In addition to his legal services to the life sciences industry, Can is also an active participant in a wide variety of pro bono matters. He has been a frequent recipient of the firm’s Pro Bono Star award and California Lawyers Association’s Wiley W. Manuel Certificate for Pro Bono Legal Services in recent years.
Prior to joining Morrison & Foerster, Can worked in a top boutique IP law firm in the United States, and then in a prestigious IP group of an international law firm as a U.S. patent agent. Can received his J.D., magna cum laude, from New York University School of Law (“NYU Law”), where he was the senior articles editor and board member of NYU Journal of Law & Business. He is a member of The Order of the Coif and the recipient of NYU Law’s only convocation award in IP law, the Walter J. Derenberg Prize. Can has a continuing scholarly research interest in patent law, particularly subject matter patent eligibility, and also in information privacy law, and has published articles in both areas.